Jean-François Bonneville
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jean-François Bonneville has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Albert Beckers
Department of Endocrinology Centre Hospitalier Universitaire de Liège, University of Liège Liège Belgium
4 shared publications Luaba Tshibanda
Department of Medical Imaging, Centre Hospitalier de Liège, Université de Liège, Domaine Universitaire du Sart Tilman, Liège, Belgium
4 shared publicationsPatrick Petrossians
Department of Endocrinology. Centre Hospitalier de Liège, Université de Liège, Domaine Universitaire du Sart Tilman, Liège, Belgium
3 shared publications- Philippe Chanson
Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse (HYPO) , Le Kremlin-Bicêtre 94275
3 shared publications - Adrian F. Daly
Department of Endocrinology, Centre Hospitalier Universitaire de Liège, University of Liège, 4000 Liège, Belgium
2 shared publications Albert Beckers
Department of Endocrinology. Centre Hospitalier de Liège, Université de Liège, Domaine Universitaire du Sart Tilman, Liège, Belgium
2 shared publications
Latest Publications
- 22 September 2022
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 107 (11) , 2982-2991
Predictive Factors of Somatostatin Receptor Ligand Response in Acromegaly—A Prospective Study
Context Somatostatin receptor ligands (SRLs) are the cornerstone medical treatments for acromegaly; however, many patients remain unresponsive to SRLs. Well-established predictive markers of response are needed. Objective We aimed to explore the relationship between responsiveness to SRLs relative to somatostatin (SST)2A and 5 receptor expression, adenoma granularity, and T2-weighted magnetic resonance imaging (MRI) signal intensity (T2WSI). Methods We conducted a multicentric, prospective, observational cohort study, in France. Forty-nine naïve patients (ie, patients without preoperative SRL treatment) with active acromegaly following surgery were treated with octreotide (group 1; n = 47), or pasireotide if uncontrolled under first-generation SRLs (group 2; n = 9). Data were collected at baseline and months 3 and 6. Biochemical measurements, immunohistochemistry studies, and MRI readings were centralized. Results In group 1, IGF-I decrease from baseline to month 6 positively correlated with SST2A immunoreactive score (IRS), P = 0.01. Densely granulated/intermediate adenomas had a greater IGF-I and GH decrease under octreotide compared with sparsely granulated adenomas (P = 0.02 and P = 0.006, respectively), and expressed greater levels of SST2A (P < 0.001), coupled with lower levels of SST5 (P = 0.004). T2WSI changed between preoperative MRI and month 6 MRI in one-half of the patients. Finally, SST5 IRS was higher in preoperative hyperintense compared with preoperative hypointense adenomas (P = 0.04), and most sparsely granulated and most hyperintense adenomas expressed high SST5 levels. Conclusion We prospectively confirm that SST2A and adenoma granularity are good predictors of response to octreotide. We propose the IRS for scoring system harmonization. MRI sequences must be optimized to be able to use the T2WSI as a predictor of treatment response.
- 22 September 2022
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 107 (11) , 2982-2991
Predictive Factors of Somatostatin Receptor Ligand Response in Acromegaly—A Prospective Study
Context Somatostatin receptor ligands (SRLs) are the cornerstone medical treatments for acromegaly; however, many patients remain unresponsive to SRLs. Well-established predictive markers of response are needed. Objective We aimed to explore the relationship between responsiveness to SRLs relative to somatostatin (SST)2A and 5 receptor expression, adenoma granularity, and T2-weighted magnetic resonance imaging (MRI) signal intensity (T2WSI). Methods We conducted a multicentric, prospective, observational cohort study, in France. Forty-nine naïve patients (ie, patients without preoperative SRL treatment) with active acromegaly following surgery were treated with octreotide (group 1; n = 47), or pasireotide if uncontrolled under first-generation SRLs (group 2; n = 9). Data were collected at baseline and months 3 and 6. Biochemical measurements, immunohistochemistry studies, and MRI readings were centralized. Results In group 1, IGF-I decrease from baseline to month 6 positively correlated with SST2A immunoreactive score (IRS), P = 0.01. Densely granulated/intermediate adenomas had a greater IGF-I and GH decrease under octreotide compared with sparsely granulated adenomas (P = 0.02 and P = 0.006, respectively), and expressed greater levels of SST2A (P < 0.001), coupled with lower levels of SST5 (P = 0.004). T2WSI changed between preoperative MRI and month 6 MRI in one-half of the patients. Finally, SST5 IRS was higher in preoperative hyperintense compared with preoperative hypointense adenomas (P = 0.04), and most sparsely granulated and most hyperintense adenomas expressed high SST5 levels. Conclusion We prospectively confirm that SST2A and adenoma granularity are good predictors of response to octreotide. We propose the IRS for scoring system harmonization. MRI sequences must be optimized to be able to use the T2WSI as a predictor of treatment response.
- 20 August 2022
- Published by Springer Nature in Pituitary
- Vol. 25 (6) , 861-867
Demonstration of the inferior intercavernous sinus is closely linked to the extent of pneumatization of the sphenoid sinus: useful information for the pituitary surgeon
Purpose To study the utility of T2-weighted MRI sequences in the identification of the inferior intercavernous sinus (IICS), a potential source of bleeding during transsphenoidal surgery of pituitary adenomas. Methods Pituitary sagittal T1W and coronal T2W MRI sequences were analyzed in 237 consecutive patients, after the exclusion of postoperative MRIs and those revealing an empty sella or a pituitary macroadenoma. Sphenoid sinus pneumatization was defined as incomplete (group 1) if it did not reach the nadir of the sella turcica, as complete (group 2) if it extended beyond the nadir of the sella or asymmetric (group 3), when only one side of the sinus was completely pneumatized. Results In Group 2 (70% of the patients), the IICS was rarely visualized on coronal T2W MRI (6/167 patients—3.6%), whereas in Group 1 it was identified in nearly all patients (55/57 patients – 96.5%, p < 0.001). In Group 3, the IICS was only visible above the non-pneumatized part of the sphenoid sinus. Conclusions The IICS can be identified on coronal T2W images in patients with an incompletely pneumatized sphenoid sinus, but very rarely in patients with a totally pneumatized sinus. This information can help to increase awareness among pituitary surgeons of the need to potentially manage IICS bleeding during transsphenoidal surgery in patients with an incompletely pneumatized sphenoid sinus.
- 20 August 2022
- Published by Springer Nature in Pituitary
- Vol. 25 (6) , 861-867
Demonstration of the inferior intercavernous sinus is closely linked to the extent of pneumatization of the sphenoid sinus: useful information for the pituitary surgeon
Purpose To study the utility of T2-weighted MRI sequences in the identification of the inferior intercavernous sinus (IICS), a potential source of bleeding during transsphenoidal surgery of pituitary adenomas. Methods Pituitary sagittal T1W and coronal T2W MRI sequences were analyzed in 237 consecutive patients, after the exclusion of postoperative MRIs and those revealing an empty sella or a pituitary macroadenoma. Sphenoid sinus pneumatization was defined as incomplete (group 1) if it did not reach the nadir of the sella turcica, as complete (group 2) if it extended beyond the nadir of the sella or asymmetric (group 3), when only one side of the sinus was completely pneumatized. Results In Group 2 (70% of the patients), the IICS was rarely visualized on coronal T2W MRI (6/167 patients—3.6%), whereas in Group 1 it was identified in nearly all patients (55/57 patients – 96.5%, p < 0.001). In Group 3, the IICS was only visible above the non-pneumatized part of the sphenoid sinus. Conclusions The IICS can be identified on coronal T2W images in patients with an incompletely pneumatized sphenoid sinus, but very rarely in patients with a totally pneumatized sinus. This information can help to increase awareness among pituitary surgeons of the need to potentially manage IICS bleeding during transsphenoidal surgery in patients with an incompletely pneumatized sphenoid sinus.
- 4 May 2022
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 107 (8) , e3313-e3320
Pituitary MRI Features in Acromegaly Resulting From Ectopic GHRH Secretion From a Neuroendocrine Tumor: Analysis of 30 Cases
Context: Ectopic acromegaly is a consequence of rare neuroendocrine tumors (NETs) that secrete GHRH. This abnormal GHRH secretion drives GH and IGF-1 excess, with a clinical presentation similar to classical pituitary acromegaly. Identifying the underlying cause for the GH hypersecretion in the setting of ectopic GHRH excess is, however, essential for proper management both of acromegaly and the NET. Owing to the rarity of NETs, the imaging characteristics of the pituitary in ectopic acromegaly have not been analyzed in depth in a large series. Objective: Characterize pituitary magnetic resonance imaging (MRI) features at baseline and after NET treatment in patients with ectopic acromegaly. Design: Multicenter, international, retrospective. Setting: Tertiary referral pituitary centers. Patients: Thirty ectopic acromegaly patients having GHRH hypersecretion. Intervention: None. Main outcome measure: MRI characteristics of pituitary gland, particularly T2-weighted signal. Results: In 30 patients with ectopic GHRH-induced acromegaly, we found that most patients had hyperplastic pituitaries. Hyperplasia was usually moderate but was occasionally subtle, with only small volume increases compared with normal ranges for age and sex. T2-weighted signal was hypointense in most patients, especially in those with hyperplastic pituitaries. After treatment of the NET, pituitary size diminished and T2-weighted signal tended to normalize. Conclusions: This comprehensive study of pituitary MRI characteristics in ectopic acromegaly underlines the utility of performing T2-weighted sequences in the MRI evaluation of patients with acromegaly as an additional tool that can help to establish the correct diagnosis.
- 4 May 2022
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 107 (8) , e3313-e3320
Pituitary MRI Features in Acromegaly Resulting From Ectopic GHRH Secretion From a Neuroendocrine Tumor: Analysis of 30 Cases
Context: Ectopic acromegaly is a consequence of rare neuroendocrine tumors (NETs) that secrete GHRH. This abnormal GHRH secretion drives GH and IGF-1 excess, with a clinical presentation similar to classical pituitary acromegaly. Identifying the underlying cause for the GH hypersecretion in the setting of ectopic GHRH excess is, however, essential for proper management both of acromegaly and the NET. Owing to the rarity of NETs, the imaging characteristics of the pituitary in ectopic acromegaly have not been analyzed in depth in a large series. Objective: Characterize pituitary magnetic resonance imaging (MRI) features at baseline and after NET treatment in patients with ectopic acromegaly. Design: Multicenter, international, retrospective. Setting: Tertiary referral pituitary centers. Patients: Thirty ectopic acromegaly patients having GHRH hypersecretion. Intervention: None. Main outcome measure: MRI characteristics of pituitary gland, particularly T2-weighted signal. Results: In 30 patients with ectopic GHRH-induced acromegaly, we found that most patients had hyperplastic pituitaries. Hyperplasia was usually moderate but was occasionally subtle, with only small volume increases compared with normal ranges for age and sex. T2-weighted signal was hypointense in most patients, especially in those with hyperplastic pituitaries. After treatment of the NET, pituitary size diminished and T2-weighted signal tended to normalize. Conclusions: This comprehensive study of pituitary MRI characteristics in ectopic acromegaly underlines the utility of performing T2-weighted sequences in the MRI evaluation of patients with acromegaly as an additional tool that can help to establish the correct diagnosis.
- 30 March 2022
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 34 (8) , e13123
Pituitary MRI in Cushing's disease ‐ an update
Pituitary MRI is essential in the diagnosis of ACTH‐dependent Cushing's syndrome, but its results are inconsistent. The demonstration of a sellar image compatible with the diagnosis of corticotropinoma varies from 40% to 90%, depending on the centre where the imaging is performed. In fact, the expertise of the neuroradiologist, use of a Tesla 3.0 MRI and choice of sequences are fundamental. The T2 and 3D gradient echo sequences after gadolinium injection are the most informative and today allow the detection of macro‐ and microadenomas in almost all cases. The diagnosis of numerous picoadenomas (<3–4 mm) is more challenging. The 2D and 3D spin echo or delayed T1 SE or FLAIR sequences after gadolinium can be used as a complement or to confirm a suspicious image. Characterization of corticotropinomas remains problematic. However, the correct assessment of so‐called incidentalomas by recognizing artifacts, anatomical variants and frequent Rathke's cleft cysts eliminates around 90% of the incidentalomas that mimic pituitary adenomas, as repetitively reported in the literature. For the time being, there is reason to believe that hybrid imaging combining PET and MRI such as 11C‐methionine PET coregistered with volumetric MRI will solve the diagnosis of corticotropinomas in the near future.
- 30 March 2022
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 34 (8) , e13123
Pituitary MRI in Cushing's disease ‐ an update
Pituitary MRI is essential in the diagnosis of ACTH‐dependent Cushing's syndrome, but its results are inconsistent. The demonstration of a sellar image compatible with the diagnosis of corticotropinoma varies from 40% to 90%, depending on the centre where the imaging is performed. In fact, the expertise of the neuroradiologist, use of a Tesla 3.0 MRI and choice of sequences are fundamental. The T2 and 3D gradient echo sequences after gadolinium injection are the most informative and today allow the detection of macro‐ and microadenomas in almost all cases. The diagnosis of numerous picoadenomas (<3–4 mm) is more challenging. The 2D and 3D spin echo or delayed T1 SE or FLAIR sequences after gadolinium can be used as a complement or to confirm a suspicious image. Characterization of corticotropinomas remains problematic. However, the correct assessment of so‐called incidentalomas by recognizing artifacts, anatomical variants and frequent Rathke's cleft cysts eliminates around 90% of the incidentalomas that mimic pituitary adenomas, as repetitively reported in the literature. For the time being, there is reason to believe that hybrid imaging combining PET and MRI such as 11C‐methionine PET coregistered with volumetric MRI will solve the diagnosis of corticotropinomas in the near future.
- 12 July 2021
- Published by Springer Nature in Pituitary
- Vol. 24 (6) , 964-969
An Infundibular Unidentified Object (IUO): a new pituitary stalk marker?
Purpose Measurement of the pituitary stalk (PS) diameter does not always solve the issue of minimal PS thickening. A previously undescribed image is found at the infundibular level on high resolution thin section T2W MRI in a large number of normal individuals. We speculate that this image—whose exact origin is still unknown—may serve as a marker of the normal infundibulum. Methods In the last 6 months, 350 consecutive adult patients suspected of sellar pathology or controlled after medical or surgical treatment prospectively underwent a pituitary MRI including a sagittal T2W high resolution sequence. One hundred twelwe patients presenting a pituitary mass with suprasellar extension or those whose PS was not entirely visible were excluded. Results A short focal annular T2 hypointense thickening of the wall of the infundibular recess of the third ventricle, more pronounced anteriorly was found in 151/238 patients. Additionally, a more or less tiny ventral extension was demonstrated on sagittal T2W sequence in 105/151 patients. These images were not identified on T1W or on T1W gadolinium enhanced sequences. The ring-like infundibular thickening and/or its ventral extension were not identified in 87/238 patients; in 43/87 of these patients the PS was found severely stretched mainly in case of primary or secondary empty sella. If patients with empty sella were excluded, our finding was observed in 194/238 cases, i.e. in 82%. Conclusions A detailed appearance of the PS on T2W MRI is described for the first time. A previously unreported T2W hypointense annular focal image prolonged by a tiny spicular or nodular ventral bud is found at the lower part of the infundibulum in a majority of normal patients, but not if the PS is stretched such as in empty sella. This image has to be recognized as a normal anatomical landmark. The possible origin of this image is discussed but not totally elucidated. An ongoing research will demonstrate or not if this image may serve as a marker to improve the early diagnosis of PS lesions.
- 12 July 2021
- Published by Springer Nature in Pituitary
- Vol. 24 (6) , 964-969
An Infundibular Unidentified Object (IUO): a new pituitary stalk marker?
Purpose Measurement of the pituitary stalk (PS) diameter does not always solve the issue of minimal PS thickening. A previously undescribed image is found at the infundibular level on high resolution thin section T2W MRI in a large number of normal individuals. We speculate that this image—whose exact origin is still unknown—may serve as a marker of the normal infundibulum. Methods In the last 6 months, 350 consecutive adult patients suspected of sellar pathology or controlled after medical or surgical treatment prospectively underwent a pituitary MRI including a sagittal T2W high resolution sequence. One hundred twelwe patients presenting a pituitary mass with suprasellar extension or those whose PS was not entirely visible were excluded. Results A short focal annular T2 hypointense thickening of the wall of the infundibular recess of the third ventricle, more pronounced anteriorly was found in 151/238 patients. Additionally, a more or less tiny ventral extension was demonstrated on sagittal T2W sequence in 105/151 patients. These images were not identified on T1W or on T1W gadolinium enhanced sequences. The ring-like infundibular thickening and/or its ventral extension were not identified in 87/238 patients; in 43/87 of these patients the PS was found severely stretched mainly in case of primary or secondary empty sella. If patients with empty sella were excluded, our finding was observed in 194/238 cases, i.e. in 82%. Conclusions A detailed appearance of the PS on T2W MRI is described for the first time. A previously unreported T2W hypointense annular focal image prolonged by a tiny spicular or nodular ventral bud is found at the lower part of the infundibulum in a majority of normal patients, but not if the PS is stretched such as in empty sella. This image has to be recognized as a normal anatomical landmark. The possible origin of this image is discussed but not totally elucidated. An ongoing research will demonstrate or not if this image may serve as a marker to improve the early diagnosis of PS lesions.
- 25 May 2020
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- Vol. 21 (2) , 235-242
Neuroimaging of aggressive pituitary tumors
Aggresssive pituitary tumors are defined as radiologically invasive, exhibiting a rapid growth and a poor response to the medical and surgical treatment options. The role of magnetic resonance imaging (MRI) is fundamental to assess tumor aggressiveness before surgical exploration. Distinction between cavernous sinus invasion and cavernous sinus compression is often challenging and cannot be solved always by using the Knosp criteria. Ideally, T2W images demonstrating the ruptured internal dural wall of cavernous sinus is the ultimate proof of cavernous sinus invasion. Subtle tumor volume increase in a short time can be shown when sequential MR images are rigorously replicable. A microcystic pattern observed on T2W images frequently reflects a potentially aggressive tumor as observed in silent corticotroph pituitary adenomas.
- 25 May 2020
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- Vol. 21 (2) , 235-242
Neuroimaging of aggressive pituitary tumors
Aggresssive pituitary tumors are defined as radiologically invasive, exhibiting a rapid growth and a poor response to the medical and surgical treatment options. The role of magnetic resonance imaging (MRI) is fundamental to assess tumor aggressiveness before surgical exploration. Distinction between cavernous sinus invasion and cavernous sinus compression is often challenging and cannot be solved always by using the Knosp criteria. Ideally, T2W images demonstrating the ruptured internal dural wall of cavernous sinus is the ultimate proof of cavernous sinus invasion. Subtle tumor volume increase in a short time can be shown when sequential MR images are rigorously replicable. A microcystic pattern observed on T2W images frequently reflects a potentially aggressive tumor as observed in silent corticotroph pituitary adenomas.
- 28 January 2019
- Published by Springer Nature in Pituitary
- Vol. 22 (1) , 100-102
Long term MRI surveillance of pituitary macroadenomas: gadolinium is not obligatory
- 28 January 2019
- Published by Springer Nature in Pituitary
- Vol. 22 (1) , 100-102
Long term MRI surveillance of pituitary macroadenomas: gadolinium is not obligatory
- 28 November 2018
- Published by Springer Nature in Pituitary
- Vol. 22 (2) , 195-197
A plea for the T2W MR sequence for pituitary imaging
- 28 November 2018
- Published by Springer Nature in Pituitary
- Vol. 22 (2) , 195-197
A plea for the T2W MR sequence for pituitary imaging
- 14 February 2017
- Published by Springer Nature in Pituitary
- Vol. 20 (1) , 116-120
T2-weighted MRI signal intensity as a predictor of hormonal and tumoral responses to somatostatin receptor ligands in acromegaly: a perspective
T2-weighted MRI signal intensity of GH-secreting pituitary adenomas is gaining recognition as a marker of disease characteristics and may be a predictor of response to treatment of acromegaly. Adenomas that are T2-hypointense are more common, are smaller and are less likely to invade the cavernous sinus compared to the T2-iso and hyperintense tumors. T2-hypointense tumors are also accompanied by higher IGF1 values at baseline. When presurgical somatostatin receptor ligand (SRL) therapy is administered, T2-hypointense adenomas have better hormonal responses and have greater tumor shrinkage. Adjuvant SRL therapy of patients with T2-hypointense tumors that are uncured by surgery is also associated with a better hormonal response. We review the studies that have dealt with the T2-weighted signal intensity of GH-secreting pituitary tumors and elaborate on the details and nuances of this promising avenue of research.
- 14 February 2017
- Published by Springer Nature in Pituitary
- Vol. 20 (1) , 116-120
T2-weighted MRI signal intensity as a predictor of hormonal and tumoral responses to somatostatin receptor ligands in acromegaly: a perspective
T2-weighted MRI signal intensity of GH-secreting pituitary adenomas is gaining recognition as a marker of disease characteristics and may be a predictor of response to treatment of acromegaly. Adenomas that are T2-hypointense are more common, are smaller and are less likely to invade the cavernous sinus compared to the T2-iso and hyperintense tumors. T2-hypointense tumors are also accompanied by higher IGF1 values at baseline. When presurgical somatostatin receptor ligand (SRL) therapy is administered, T2-hypointense adenomas have better hormonal responses and have greater tumor shrinkage. Adjuvant SRL therapy of patients with T2-hypointense tumors that are uncured by surgery is also associated with a better hormonal response. We review the studies that have dealt with the T2-weighted signal intensity of GH-secreting pituitary tumors and elaborate on the details and nuances of this promising avenue of research.
- 11 February 2016
- Published by Bioscientifica in Endocrine Abstracts
Bifocal intracranial germinoma presenting as adipsic diabetes insipidus
Introduction: Intracranial germ-cell tumors (GCT) are rare, occurring in less than 4% of pediatric patients. Histologically, they are divided into several types, among which germinomatous GCTs represent over 50% of cases. Depending on their location, GCTs usually present with symptoms of intracranial hypertension for pineal lesions, whereas suprasellar ones lead to visual disturbances or pituitary hormonal defects. We present the case of a bifocal intracranial germinoma with an unusual clinical presentation of adipsic diabetes insipidus, a condition with significant morbidity and mortality. Case report: A 19-year-old female patient was addressed to the emergency department with fatigue, dizziness and unsteady gait. She reported a rapid decline of visual function over the previous 15 days, although certain complaints (blurred vision of the right eye, considered to be due to myopia) had already been investigated 2 years earlier. Clinically, the patient was dehydrated, with normal blood pressure, but tachycardic. Homonymous left lateral hemianopsia was objectified as well as severely impaired vision (1/10 – right eye, 2/10 – left eye). Biochemistry found severe hypernatremia – 177 mmol/l with hyperosmolality – 379 mOsm/kg and acute prerenal renal failure. Urines were normally diluted and thirst sensation was lost. Cerebral MRI revealed two lesions in the suprasellar and pineal regions with intense contrast-enhancement, compatible with GCTs. The suprasellar lesion extended up to the lateral ventricular floor. Further hormonal evaluation revealed pan-hypopituitarism and hyperprolactinemia most likely due to stalk compression. Tumor markers (AFP and bhCG) were negative in serum, while bhCG was slightly elevated in CSF. As the lesion was bifocal, with slightly elevated tumor markers, it was considered a germinoma. Treatment with chemotherapy and adjuvant radiotherapy was decided. The favorable response to treatment confirmed the diagnosis. Conclusion: We report the case of a bifocal germinoma presenting as adipsic diabetes insipidus. To our knowledge, this is the case of intracranial CGT with this presentation. In our patient’s history, a period of polydipsia and polyuria was noted several months prior to diagnosis, but medical attention was not sought at the time. As the lesion expanded towards the hypothalamus, thirst sensation was lost, therefore leading to adipsic diabetes insipidus. Our case also underlines the importance of a thorough investigation of apparently benign symptoms, such as visual complaints or polyuria/polydipsia, especially when occurring simultaneously.
- 11 February 2016
- Published by Bioscientifica in Endocrine Abstracts
Bifocal intracranial germinoma presenting as adipsic diabetes insipidus
Introduction: Intracranial germ-cell tumors (GCT) are rare, occurring in less than 4% of pediatric patients. Histologically, they are divided into several types, among which germinomatous GCTs represent over 50% of cases. Depending on their location, GCTs usually present with symptoms of intracranial hypertension for pineal lesions, whereas suprasellar ones lead to visual disturbances or pituitary hormonal defects. We present the case of a bifocal intracranial germinoma with an unusual clinical presentation of adipsic diabetes insipidus, a condition with significant morbidity and mortality. Case report: A 19-year-old female patient was addressed to the emergency department with fatigue, dizziness and unsteady gait. She reported a rapid decline of visual function over the previous 15 days, although certain complaints (blurred vision of the right eye, considered to be due to myopia) had already been investigated 2 years earlier. Clinically, the patient was dehydrated, with normal blood pressure, but tachycardic. Homonymous left lateral hemianopsia was objectified as well as severely impaired vision (1/10 – right eye, 2/10 – left eye). Biochemistry found severe hypernatremia – 177 mmol/l with hyperosmolality – 379 mOsm/kg and acute prerenal renal failure. Urines were normally diluted and thirst sensation was lost. Cerebral MRI revealed two lesions in the suprasellar and pineal regions with intense contrast-enhancement, compatible with GCTs. The suprasellar lesion extended up to the lateral ventricular floor. Further hormonal evaluation revealed pan-hypopituitarism and hyperprolactinemia most likely due to stalk compression. Tumor markers (AFP and bhCG) were negative in serum, while bhCG was slightly elevated in CSF. As the lesion was bifocal, with slightly elevated tumor markers, it was considered a germinoma. Treatment with chemotherapy and adjuvant radiotherapy was decided. The favorable response to treatment confirmed the diagnosis. Conclusion: We report the case of a bifocal germinoma presenting as adipsic diabetes insipidus. To our knowledge, this is the case of intracranial CGT with this presentation. In our patient’s history, a period of polydipsia and polyuria was noted several months prior to diagnosis, but medical attention was not sought at the time. As the lesion expanded towards the hypothalamus, thirst sensation was lost, therefore leading to adipsic diabetes insipidus. Our case also underlines the importance of a thorough investigation of apparently benign symptoms, such as visual complaints or polyuria/polydipsia, especially when occurring simultaneously.